Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Bradley Martin

Concepts (327)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Analgesics, Opioid
40
2024
568
8.650
 Why?
Chronic Pain
17
2024
174
6.030
 Why?
Opioid-Related Disorders
17
2024
389
4.230
 Why?
Drug Overdose
10
2024
160
3.300
 Why?
Medicaid
23
2021
258
2.830
 Why?
Drug Prescriptions
14
2024
95
2.710
 Why?
Tramadol
3
2024
30
2.470
 Why?
Alcoholism
4
2022
232
2.460
 Why?
Cross-Over Studies
2
2025
224
1.800
 Why?
Retrospective Studies
38
2024
6223
1.730
 Why?
Antipsychotic Agents
9
2018
230
1.710
 Why?
Adult
56
2025
13568
1.710
 Why?
United States
49
2024
4913
1.640
 Why?
Middle Aged
54
2025
12460
1.600
 Why?
Osteoarthritis, Knee
3
2017
91
1.540
 Why?
Humans
96
2025
50389
1.470
 Why?
Pain
10
2018
374
1.460
 Why?
Adolescent
37
2025
6475
1.370
 Why?
Health Care Costs
9
2016
168
1.360
 Why?
Medication Adherence
7
2016
129
1.310
 Why?
Young Adult
27
2025
4064
1.290
 Why?
Viscosupplements
3
2017
14
1.270
 Why?
Anticoagulants
5
2023
254
1.270
 Why?
Female
66
2025
26981
1.260
 Why?
Hyaluronic Acid
3
2017
35
1.250
 Why?
Male
63
2025
25718
1.230
 Why?
Aged
38
2025
9590
1.200
 Why?
Emergency Service, Hospital
6
2016
482
1.170
 Why?
Schizophrenia
5
2009
258
1.120
 Why?
Arthroplasty, Replacement, Knee
4
2017
284
1.070
 Why?
Analgesics, Non-Narcotic
3
2012
115
1.070
 Why?
Substance-Related Disorders
5
2021
595
1.050
 Why?
Acetaminophen
4
2015
274
1.040
 Why?
Patient Compliance
6
2009
231
1.010
 Why?
Veterans
10
2024
572
0.970
 Why?
Cohort Studies
14
2024
1426
0.950
 Why?
Atrial Fibrillation
3
2016
189
0.950
 Why?
Psychotropic Drugs
1
2025
76
0.930
 Why?
Arkansas
15
2025
1991
0.920
 Why?
Asthma
3
2015
282
0.880
 Why?
Suicide
1
2025
82
0.880
 Why?
Prescription Drugs
6
2014
38
0.870
 Why?
Cost-Benefit Analysis
5
2020
270
0.860
 Why?
Insurance, Health
7
2020
124
0.830
 Why?
Venous Thromboembolism
1
2023
67
0.800
 Why?
Attention Deficit Disorder with Hyperactivity
1
2023
173
0.780
 Why?
Neck Pain
2
2021
10
0.780
 Why?
Back Pain
2
2021
38
0.760
 Why?
Drug Utilization
11
2017
75
0.760
 Why?
Central Nervous System Stimulants
1
2023
205
0.750
 Why?
Hospitalization
6
2016
668
0.750
 Why?
Arthralgia
1
2021
43
0.740
 Why?
Professional-Patient Relations
1
2021
48
0.730
 Why?
Insurance, Pharmaceutical Services
2
2019
25
0.720
 Why?
Mental Disorders
7
2025
404
0.710
 Why?
Narcotic Antagonists
2
2024
135
0.690
 Why?
Logistic Models
8
2016
900
0.690
 Why?
Naloxone
1
2020
79
0.660
 Why?
Hydrocodone
3
2024
20
0.640
 Why?
Oxycodone
3
2024
26
0.640
 Why?
Warfarin
3
2016
83
0.640
 Why?
Legislation, Drug
1
2019
17
0.630
 Why?
Contraception
1
2019
29
0.620
 Why?
Decision Support Techniques
2
2016
71
0.620
 Why?
Proton Pump Inhibitors
2
2016
85
0.620
 Why?
Adrenal Cortex Hormones
2
2017
100
0.600
 Why?
Follow-Up Studies
8
2024
2219
0.580
 Why?
Guidelines as Topic
1
2018
110
0.570
 Why?
Mammography
1
2018
100
0.570
 Why?
Buprenorphine
3
2024
146
0.570
 Why?
Practice Guidelines as Topic
3
2017
460
0.560
 Why?
Histamine H2 Antagonists
1
2016
26
0.550
 Why?
Peptic Ulcer
1
2016
14
0.550
 Why?
Purinergic P2Y Receptor Antagonists
3
2022
29
0.530
 Why?
Education, Pharmacy, Graduate
1
2016
19
0.520
 Why?
Pyridones
1
2016
35
0.520
 Why?
Risk
4
2020
316
0.510
 Why?
Inappropriate Prescribing
1
2016
22
0.500
 Why?
Safety-Based Drug Withdrawals
1
2015
7
0.500
 Why?
Dextropropoxyphene
1
2015
6
0.500
 Why?
Health Expenditures
3
2011
71
0.500
 Why?
For-Profit Insurance Plans
1
2015
2
0.500
 Why?
Brain Ischemia
2
2016
159
0.490
 Why?
Risk Factors
11
2024
3692
0.490
 Why?
Pyrazoles
1
2016
111
0.490
 Why?
Mass Screening
1
2018
348
0.480
 Why?
Quinolines
1
2015
41
0.480
 Why?
Stress, Psychological
1
2016
261
0.480
 Why?
Acetates
1
2015
49
0.470
 Why?
Time Factors
9
2018
2934
0.470
 Why?
Opiate Substitution Treatment
3
2024
95
0.470
 Why?
Diabetic Neuropathies
1
2015
53
0.470
 Why?
Anticonvulsants
2
2006
125
0.470
 Why?
Insurance Claim Reporting
2
2011
11
0.460
 Why?
Critical Illness
1
2016
300
0.450
 Why?
Insurance Claim Review
4
2010
36
0.450
 Why?
Curriculum
2
2018
398
0.450
 Why?
Pain Management
1
2015
172
0.440
 Why?
Palliative Care
1
2016
188
0.440
 Why?
Stroke
2
2016
485
0.440
 Why?
Neoplasms
1
2023
1237
0.430
 Why?
Breast Neoplasms
2
2023
1189
0.430
 Why?
Databases, Factual
8
2022
667
0.420
 Why?
Injections, Intra-Articular
3
2017
33
0.420
 Why?
Computers, Handheld
1
2013
25
0.420
 Why?
Prescription Drug Misuse
3
2024
33
0.420
 Why?
United States Department of Veterans Affairs
5
2024
288
0.410
 Why?
Age Factors
6
2018
1104
0.400
 Why?
Benzodiazepines
3
2024
70
0.390
 Why?
Cross-Sectional Studies
6
2022
1590
0.390
 Why?
Health Personnel
2
2016
252
0.370
 Why?
Community Pharmacy Services
3
2020
66
0.360
 Why?
Kidney Failure, Chronic
2
2022
200
0.340
 Why?
Case-Control Studies
6
2023
1148
0.330
 Why?
Motor Vehicles
1
2009
15
0.320
 Why?
Antidepressive Agents
2
2009
176
0.320
 Why?
Automobile Driving
1
2009
22
0.320
 Why?
Medication Errors
1
2009
25
0.320
 Why?
Pharmacists
3
2019
145
0.310
 Why?
Cost of Illness
3
2013
113
0.300
 Why?
Physicians, Primary Care
2
2018
46
0.300
 Why?
Quality-Adjusted Life Years
2
2020
63
0.300
 Why?
Pain Measurement
6
2021
248
0.290
 Why?
Health Resources
2
2012
74
0.290
 Why?
College Admission Test
2
2018
13
0.290
 Why?
Antimanic Agents
1
2007
14
0.280
 Why?
School Admission Criteria
2
2018
35
0.280
 Why?
Hypoglycemic Agents
1
2008
174
0.280
 Why?
Schools, Pharmacy
2
2018
53
0.270
 Why?
Pharmaceutical Services
2
2018
52
0.270
 Why?
Propensity Score
2
2017
131
0.270
 Why?
Constipation
1
2006
33
0.270
 Why?
Orthopedic Procedures
2
2017
70
0.270
 Why?
Overweight
1
2009
217
0.270
 Why?
Least-Squares Analysis
4
2011
42
0.260
 Why?
Medicare
4
2023
245
0.260
 Why?
Georgia
5
2006
42
0.260
 Why?
Platelet Aggregation Inhibitors
2
2021
174
0.260
 Why?
Knee Joint
2
2017
161
0.260
 Why?
Students, Pharmacy
2
2018
124
0.250
 Why?
Odds Ratio
4
2020
551
0.250
 Why?
Multivariate Analysis
3
2017
583
0.240
 Why?
Controlled Substances
1
2024
6
0.240
 Why?
Child
9
2019
6877
0.240
 Why?
Risperidone
2
2010
25
0.240
 Why?
North Carolina
5
2011
53
0.240
 Why?
Polypharmacy
1
2004
15
0.240
 Why?
Aged, 80 and over
8
2023
3180
0.230
 Why?
Drug Costs
2
2020
39
0.230
 Why?
Renal Dialysis
2
2022
171
0.220
 Why?
Haloperidol
1
2003
47
0.220
 Why?
Hemorrhage
2
2023
197
0.210
 Why?
Direct Service Costs
1
2003
5
0.210
 Why?
Irritable Bowel Syndrome
1
2003
17
0.210
 Why?
Employment
1
2003
90
0.210
 Why?
Dose-Response Relationship, Drug
5
2014
1356
0.210
 Why?
Aftercare
1
2023
74
0.210
 Why?
Prevalence
4
2018
970
0.210
 Why?
Premedication
1
2002
17
0.200
 Why?
Age Distribution
4
2018
170
0.200
 Why?
Diabetes Mellitus, Type 2
1
2008
516
0.200
 Why?
Health Services Needs and Demand
1
2004
155
0.200
 Why?
Neuralgia
1
2023
63
0.200
 Why?
Common Cold
1
2002
5
0.200
 Why?
Bronchitis
1
2002
11
0.200
 Why?
Proportional Hazards Models
4
2017
418
0.200
 Why?
Thromboembolism
1
2002
55
0.190
 Why?
Accidents
1
2021
21
0.190
 Why?
Carcinoma, Non-Small-Cell Lung
1
2023
152
0.190
 Why?
Depressive Disorder, Major
2
2020
150
0.190
 Why?
Forecasting
3
2009
147
0.190
 Why?
Ambulatory Care Facilities
1
2002
121
0.190
 Why?
Mental Health Services
1
2004
202
0.180
 Why?
Respiratory Tract Infections
1
2002
76
0.180
 Why?
Interprofessional Relations
2
2018
84
0.180
 Why?
Patient Discharge
1
2023
322
0.180
 Why?
Afghan Campaign 2001-
2
2018
40
0.180
 Why?
Administration, Oral
2
2016
432
0.180
 Why?
Obesity
1
2009
1125
0.180
 Why?
United States Food and Drug Administration
3
2011
91
0.170
 Why?
Administration, Intranasal
1
2020
30
0.170
 Why?
Markov Chains
1
2020
31
0.170
 Why?
Cardiovascular Diseases
2
2018
455
0.170
 Why?
Brain Neoplasms
1
2023
288
0.170
 Why?
Social Media
1
2022
98
0.170
 Why?
Preventive Health Services
1
2020
49
0.160
 Why?
Child, Preschool
5
2011
3908
0.160
 Why?
Regression Analysis
4
2013
396
0.160
 Why?
Drug Administration Schedule
3
2011
369
0.160
 Why?
Sepsis
1
2021
227
0.160
 Why?
Delivery of Health Care
1
2021
308
0.160
 Why?
Insurance Coverage
1
2020
110
0.160
 Why?
Health Care Surveys
2
2011
173
0.150
 Why?
Public Health Surveillance
1
2018
14
0.150
 Why?
Thiazoles
2
2016
53
0.150
 Why?
Sleep Deprivation
1
2018
16
0.150
 Why?
Papillomavirus Vaccines
1
2019
67
0.150
 Why?
Pharmacies
1
2019
60
0.150
 Why?
Physicians
1
2021
229
0.150
 Why?
Advisory Committees
1
2018
61
0.150
 Why?
Chronic Disease
5
2011
570
0.150
 Why?
Metabolic Diseases
1
2018
40
0.150
 Why?
Lung Neoplasms
1
2023
600
0.140
 Why?
Veterans Health
2
2014
62
0.140
 Why?
Molecular Weight
1
2017
85
0.140
 Why?
Acute Pain
1
2017
9
0.140
 Why?
Papillomavirus Infections
1
2019
168
0.140
 Why?
Treatment Outcome
7
2010
5230
0.140
 Why?
Educational Measurement
1
2018
205
0.140
 Why?
Monte Carlo Method
1
2016
86
0.130
 Why?
Early Detection of Cancer
1
2018
165
0.130
 Why?
Anti-Bacterial Agents
1
2002
745
0.130
 Why?
Education, Pharmacy
1
2018
146
0.130
 Why?
Health Services Accessibility
1
2020
420
0.130
 Why?
Geriatrics
1
2016
45
0.120
 Why?
Postoperative Complications
1
2002
1035
0.120
 Why?
Sulfides
1
2015
28
0.120
 Why?
Models, Theoretical
1
2016
174
0.120
 Why?
Cyclopropanes
1
2015
24
0.120
 Why?
Pyridines
1
2016
132
0.120
 Why?
Renal Insufficiency, Chronic
1
2018
174
0.120
 Why?
Thrombosis
1
2018
249
0.120
 Why?
Anti-Asthmatic Agents
1
2015
29
0.120
 Why?
Societies, Medical
1
2016
179
0.120
 Why?
Severity of Illness Index
2
2016
963
0.120
 Why?
Self Report
1
2016
203
0.120
 Why?
Long-Term Care
3
2012
50
0.110
 Why?
Health Literacy
1
2016
129
0.110
 Why?
California
2
2004
87
0.110
 Why?
Comorbidity
5
2017
617
0.110
 Why?
Prescriptions
2
2011
10
0.100
 Why?
Risk Assessment
2
2015
1258
0.100
 Why?
Monitoring, Physiologic
1
2013
121
0.100
 Why?
Sensitivity and Specificity
1
2015
875
0.100
 Why?
Guideline Adherence
2
2023
133
0.100
 Why?
Infant
3
2011
3601
0.100
 Why?
Managed Care Programs
1
2012
36
0.100
 Why?
Ticlopidine
1
2012
55
0.100
 Why?
Deductibles and Coinsurance
1
2011
2
0.090
 Why?
Hypertension, Pulmonary
1
2012
123
0.090
 Why?
Body Mass Index
2
2013
669
0.080
 Why?
Health Policy
1
2011
152
0.080
 Why?
Calibration
1
2009
58
0.080
 Why?
International Classification of Diseases
1
2009
64
0.080
 Why?
Clozapine
2
2010
26
0.080
 Why?
Reference Values
1
2009
312
0.080
 Why?
Analysis of Variance
1
2010
562
0.080
 Why?
Treatment Refusal
1
2009
35
0.080
 Why?
Evidence-Based Medicine
1
2010
249
0.080
 Why?
Carbamazepine
1
2007
13
0.070
 Why?
Mental Health
1
2010
222
0.070
 Why?
Lithium Compounds
1
2007
11
0.070
 Why?
Alendronate
1
2007
23
0.070
 Why?
Valproic Acid
1
2007
32
0.070
 Why?
Fractures, Spontaneous
1
2007
14
0.070
 Why?
Chemotherapy, Adjuvant
1
2007
121
0.070
 Why?
Osteoporosis, Postmenopausal
1
2007
28
0.070
 Why?
Affect
1
2007
98
0.070
 Why?
Drug Labeling
1
2006
11
0.070
 Why?
Bone Density Conservation Agents
1
2007
74
0.070
 Why?
Predictive Value of Tests
1
2008
934
0.060
 Why?
Adrenergic beta-Agonists
1
2005
41
0.060
 Why?
Self Disclosure
1
2005
13
0.060
 Why?
Drug Interactions
2
2018
208
0.060
 Why?
Depression
1
2009
572
0.060
 Why?
Eligibility Determination
1
2004
17
0.060
 Why?
Factor Analysis, Statistical
1
2004
76
0.060
 Why?
Urban Population
1
2005
152
0.060
 Why?
Health Surveys
2
2018
236
0.060
 Why?
Prescription Fees
1
2004
14
0.060
 Why?
Length of Stay
1
2007
627
0.060
 Why?
Algorithms
1
2007
618
0.050
 Why?
Drug Therapy, Combination
1
2004
383
0.050
 Why?
MEDLINE
1
2002
7
0.050
 Why?
Prospective Studies
1
2008
2414
0.050
 Why?
Enoxaparin
1
2002
27
0.050
 Why?
Cognition Disorders
1
2003
199
0.050
 Why?
Neuropsychological Tests
1
2003
337
0.050
 Why?
Gastrointestinal Hemorrhage
1
2022
79
0.050
 Why?
Longitudinal Studies
2
2014
709
0.050
 Why?
Data Collection
1
2002
283
0.040
 Why?
Patient Protection and Affordable Care Act
1
2020
51
0.040
 Why?
Needs Assessment
1
2020
135
0.040
 Why?
Quality of Health Care
1
2020
184
0.040
 Why?
Incidence
2
2014
1017
0.040
 Why?
Pharmacoepidemiology
1
2017
8
0.040
 Why?
Pharmacy
1
2018
54
0.040
 Why?
Universities
1
2018
170
0.040
 Why?
Vaccination
1
2019
275
0.030
 Why?
Pilot Projects
1
2019
704
0.030
 Why?
Communication
1
2018
246
0.030
 Why?
Electronic Health Records
1
2018
214
0.030
 Why?
Qualitative Research
1
2018
338
0.030
 Why?
Reminder Systems
1
2016
27
0.030
 Why?
Decision Making
1
2018
273
0.030
 Why?
Medication Therapy Management
1
2016
24
0.030
 Why?
Attitude of Health Personnel
1
2018
349
0.030
 Why?
Ischemic Attack, Transient
1
2013
57
0.030
 Why?
Survival Analysis
1
2014
671
0.030
 Why?
Lipids
1
2013
149
0.030
 Why?
Linear Models
1
2013
279
0.030
 Why?
Stress Disorders, Post-Traumatic
1
2017
377
0.020
 Why?
Diagnosis, Dual (Psychiatry)
1
2012
41
0.020
 Why?
Diagnostic Tests, Routine
1
2012
29
0.020
 Why?
Cost Control
1
2011
13
0.020
 Why?
Acute Coronary Syndrome
1
2012
78
0.020
 Why?
Blood Pressure
1
2013
529
0.020
 Why?
Blood Glucose
1
2013
443
0.020
 Why?
Dibenzothiazepines
1
2010
10
0.020
 Why?
Adolescent Behavior
1
2011
105
0.020
 Why?
Hypnotics and Sedatives
1
2010
74
0.020
 Why?
Off-Label Use
1
2010
26
0.020
 Why?
Diabetes Mellitus
1
2013
284
0.020
 Why?
Mood Disorders
1
2009
58
0.020
 Why?
Quinolones
1
2010
42
0.020
 Why?
Anxiety Disorders
1
2009
125
0.020
 Why?
Piperazines
1
2010
118
0.020
 Why?
Headache
1
2008
76
0.020
 Why?
Sex Factors
1
2009
702
0.020
 Why?
Confidence Intervals
1
2007
154
0.020
 Why?
Probability
1
2007
165
0.020
 Why?
Drug Utilization Review
1
2005
23
0.020
 Why?
Drug Monitoring
1
2005
78
0.010
 Why?
Bone Density
1
2007
385
0.010
 Why?
Registries
1
2007
539
0.010
 Why?
Quality of Life
1
2008
844
0.010
 Why?
Reproducibility of Results
1
2005
1201
0.010
 Why?
Martin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (327) concept(s)
_
Co-Authors Expand Description
See all (49) people
_
Similar People Expand Description
See all (37) people
_
Same Department Expand Description
Search Department